CARB-X partnership pushes development of new antibiotics
July 28, 2019
TRENTON, N.J. (AP) — For decades, bacteria have been figuring out ways to outsmart the antibiotics that once easily killed them. Partly due to overuse, the bugs' ability to resist antibiotics is rising, as are the cost and time to treat patients.
Meanwhile, fewer drugmakers are developing new antibiotics, thanks to the economics: Antibiotics are inexpensive, and patients only take them briefly. Drug companies reap far bigger profits from medicines that people take for years.
Drug-resistant bacterial infections annually kill about 23,000 Americans and 700,000 people worldwide. So foundatio...